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Abstract 
Cancer survivors meet survivorship with uncertainty due to a lack of uniform information 
provided post cancer treatment. The implementation of survivorship care plans (SCP) has been 
recognized by key stakeholders as the solution to transitional uncertainties. 
In fact, to achieve accreditation by the Commission on Cancer (CoC) cancer centers are required 
to deliver SCPs to cancer survivors within a year of their treatment completion. Research 
demonstrates SCP delivery results in significant improvement in patient satisfaction, 
coordination of care, and survivorship care knowledge. In order to meet CoC standard 3.3 and 
bring understanding to SCPs function in cancer survivorship care a quality improvement project 
was initiated within an Arizona cancer center. SCPs were delivered at a survivorship visit to 
adult breast cancer patients. SCPs affect on survivors’ confidence in cancer self-care knowledge 
and care satisfaction was evaluated as well as the organization’s adherence to CoC standard 3.3 
requirements. Identified survivors were scheduled for a survivorship visit where a SCP was 
delivered by a oncology provider. Survivors perceived confidence in knowledge and satisfaction 
was measured using the modified 16-item Confidence in Survivorship Information Questionnaire 
(CSI). Questionnaires were completed pre and post survivorship visit. A paired t-test analysis 
was used to evaluate SCP effectiveness. There was an increase in the delivery of SCPs from zero 
to 57 with an 84 percent SCP delivery from August 2017 to January 2018. Survivors and 
providers verbalize value in SCPs. No statistical significance was found in the comparison of 
SCPs affect on survivors’ confidence in cancer self-care knowledge and care satisfaction to that 
of standard follow-up care; however, when comparing the pre/post questionnaire averages an 
improvement was noted across the board.The prospect of this project is to unveil the impact SCP 
delivery at a survivorship visit has on the selected metrics. This project aids as a director for 
organization wide implementation for CoC standard 3.3 requirement compliance.  
 
Keywords: survivorship, care plan, survivorship care plan, cancer, neoplasm, breast 
cancer, breast neoplasm, confidence, self-efficacy, satisfaction, health promotion, follow-
up recommendations, and follow-up adherence 
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Survivorship Care Planning 
With medical advances in cancer treatment, detection, and supportive care the number of 
cancer survivors has exponentially grown (Rowland & Yancik, 2006). Of those diagnosed with 
cancer, two of three persons are expected to live at least five years past their diagnosis. 
Currently, 14 million cancer survivors live in the United States. By 2024 this number is expected 
to be more than 18 million (Centers for Disease Control and Prevention, 2016). 
Problem 
Reaching survivorship for cancer patients is a great triumph; however, the completion of 
treatment marks the beginning of another battle. Several challenges have been found in the realm 
of the continuation of post cancer treatment care. These challenges include the ambiguity of 
follow-up care and long-term effects and health risks due to cancer diagnosis and treatment 
which affect the physical, psychosocial, and emotional well-being of the survivor (Nolte et al., 
2016; Sprague et al., 2013). The uncertainty of follow-up care is due to oncologists’ inability to 
continue as the predominant provider in survivorship care with the increase of their patient 
population (Boeknout et al., 2014). This has placed survivorship care in the hands of primary 
care providers (PCPs), who along with survivors are uncertain of follow-up care for appropriate 
screening and surveillance (Jackson, Scheid, & Rolnick, 2013). This is due to the lack of care 
coordination during the transition phase from a cancer patient to a survivor (Salz & Baxi, 2016). 
Long-term physical, psychosocial, and emotional effects may include, but are not limited to: 
pain, fatigue, and psychological distress. Also, cancer survivors are at a higher risk of acquiring 
hypertension, diabetes, dyslipidemias, and becoming obese (Sisler, Chaput, Sussman, & 
Ozokwelu, 2016). If the survivor is unaware of these effects and risks it is difficult for them to 
optimize their own well-being and take the appropriate steps to prevent further health issues.  
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With the continuing evolution of the cancer survivor population it is important for 
survivors and providers to understand follow-up care and the unique physical, psychosocial, and 
emotional effects and risks of survivorship (DeSantis et al., 2014). Lack of understanding 
increases the survivors’ chances of acquiring and mismanaging long-term effects and chronic 
health issues. Also, the survivor may neglect cancer surveillance recommendations that identify 
cancer recurrence. Without proper survivorship care the survivor may not be able to make a 
successful transition from a patient to a survivor (Bulloch et al., 2017).  
Purpose and Rationale 
 In 2006, the Institute of Medicine (IOM) released the report From Cancer Patient to 
Cancer Survivor: Lost in Transition that brought attention to the inadequacies of current 
survivorship care. In an attempt to correct these inadequacies the IOM identified four essential 
components of survivorship care (a) prevention and detection of cancers (new or recurrent), (b) 
surveillance for cancer (spread, reassurance, or secondary), (c) interventions for long-term 
effects of cancer diagnosis and treatment, and (d) care coordination between providers in order to 
meet survivors specific needs (IOM & National Research Council [NRC], 2006). Alongside 
these essential survivorship components the IOM proposed 10 recommendations to help improve 
survivorship care, one of which stated that each cancer survivor should be given a SCP upon the 
completion of their primary treatment (Klemanski, Browning, & Kue, 2015). This SCP includes 
the survivors complete care summary (cancer diagnosis and treatment), possible long-term 
effects, surveillance and lifestyle recommendations, and provider identification in regard to who 
will be in charge of care (Bulloch et al., 2017). This specific recommendation has shown to be 
important among many key cancer stakeholders such as the American Society of Clinical 
Oncology (ASCO), American Cancer Society (ACS), National Comprehensive Cancer Network, 
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National Cancer Institute’s Office of Cancer Survivorship, National Coalition for Cancer 
Survivorship, Oncology Nursing Society, and LIVESTRONG. All have endorsed the IOM 
recommendation for SCPs (Klemanski, Browning, & Kue, 2016). The CoC has taken this 
recommendation a step further and is requiring that by 2018 at least 75 percent of cancer 
survivors must receive a SCP at the time of the survivor’s initial cancer treatment completion in 
order to be deemed a cancer center (Commission on Cancer, 2014). Despite key stakeholders 
efforts many health care systems and cancer centers have shown inconsistency with the 
implementation and deliverance of SCPs (Klemanski, Browning, & Kue, 2016). This paper 
investigates the use of SCPs through a current literature review, reviews the positive potential of 
SCPs, the challenges they present, and a review of the evidence surrounding them.  
Background and Significance  
The importance of SCPs has been unremittingly acknowledged in the cancer reform 
agenda for over a decade. However, despite organizational support, some evidence, and face 
validity, only a few cancer centers have implemented them within their practice routine (Nolte et 
al., 2016). Fifty-six percent of cancer programs in the United States admit to not using SCPs 
(Birken, Deal, Mayer, & Weiner, 2014). This has resulted in a lack of understanding as to how 
they impact both patients and providers in the transition of survivorship care (Nolte et al., 2016). 
Cancer survivors are uncertain as to what comes next in their transition from patient to survivor. 
Survivors are both fearful and uncertain about their survivorship. Although they are relieved to 
have completed treatment, they are unsure where this leaves them in relationship to their 
providers, and who is responsible for follow-up care and surveillance (Haq et al., 2013). 
Healthcare providers have conflicting perspectives on their roles in survivorship care, which is 
detrimental to the survivor as it may result in excess testing or worse, the omission of 
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recommended follow-up surveillance (Birken, Deal, Mayer, Weiner, 2014).  SCPs are meant to 
provide direction for survivors to improve health outcomes, clarify providers’ responsibilities, 
and decrease gaps in survivorship care (IOM & NRC, 2006). These care plans further encourage 
care coordination, communication between providers, improved survivorship care knowledge, 
and the understanding of needs that a survivor may have in their future (Forsythe et al., 2013). 
Survivors must be given information in order to be their own advocate. SCPs are intended to 
provide this information to improve patient advocacy (Keesing, McNamara, & Rosenwax, 2015).  
Although the amount of high-level evidence in the support of SCPs is limited, there have 
been several studies that have found benefits in the areas of survivor and provider satisfaction, 
improving knowledge related to the survivor’s diagnosis and treatment, and improved 
communication between the survivor and their providers (Nolte et al., 2016). Haq et al (2013) 
conducted a qualitative pilot study that found SCPs to effectively address survivorship follow-up 
needs. Faul et al. (2014) reported that SCPs improved survivorship care knowledge within older 
breast cancer survivors. Oancea & Cheruvu (2016) found that SCPs benefit survivor’s 
psychological well-being. Bulloch et al. (2015) noted that 100 percent of breast cancer survivors 
were interesting in getting a SCP. Two randomized control trials showed higher satisfaction rates 
in follow-up care for breast cancer survivors after receiving a SCP (Brennan, Gormally, Butow, 
Boyle, & Spillane, 2014). Blaauwbroek et al., (2012) found that adherence to follow-up 
recommendations was higher in survivors who provided their PCP with a SCP. Providers are 
shown to benefit from SCPs as well. Forsythe et al (2013) illustrated improved care coordination, 
communication, and confidence in providers’ knowledge of survivorship care post SCP receipt.  
In a multicenter trial participants were found to have improved satisfaction of care, survivorship 
knowledge, and care coordination after the implementation of a SCP (Palmer et al., 2015).  
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The current literature consistently calls for continued research. Barriers such as the 
implementation process, reimbursement, institutional resources, and time constraints need to be 
explored (Palmer et al., 2015). Tompkins and O’ Brien (2014) emphasized the importance of 
defining who is responsible for the coordination of survivors’ follow-up care through further 
research. Other authors focused on the facilitation, creation, and implementation process of SCPs 
(Forsythe et al., 2013). In a systematic review of qualitative studies, Keesing, McNamara, & 
Rosenwax (2015) found that although stakeholders agreed upon the importance of SCPs in 
survivorship care there is a lack of consensus on SCP format and deliverance, inconsistency of 
SCP reciprocation, and little high-level evidence to support the use of SCPs. Another area of 
research that was suggested is which key cancer survivor populations should be focused on. 
Forty percent of women cancer survivors are breast cancer survivors, it is recommended that 
future studies should be focused on breast and colon cancer survivors due to the fact that they 
make up most of the survivorship population to date (Salz & Baxi, 2016; Bulloch et al., 2015; 
Miller, 2008).  
 SCPs effect on survivors’ confidence in self-care and health promotion are other 
outcome metrics that require further research. Arora et al. (2011) reported 59 percent of 
survivors stated limited to no health promotion or prevention aspects were addressed in their 
follow-up care. Kvale et al. (2016) conducted a randomized control trial (RCT) and found that 
survivors who received SCPs reported higher self health and efficacy. This study illustrated the 
positive impact SCPs can have on survivors’ self-care and health promotion. Breast cancer 
survivors reported higher understanding of their follow-up care and self-efficacy after receiving a 
SCP compared to survivors who did not (Ezendam et al., 2014). Limited evidence exists in 
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relation to SCPs and survivors health benefits, therefore, more studies should aim to identify this 
relation (Mayer, Birken, Check, & Chen, 2015).  
Internal Evidence and PICO 
It has become evident to a cancer center in the metropolitan Phoenix area that there is 
much need and opportunity for an evidence-based practice project within the realm of cancer 
survivorship care. Currently, this cancer center is in the process of figuring out how to 
implement survivorship care plans within two pilot groups, the breast and colon cancer 
survivors. The process of implementation has not begun. This is an issue because of the looming 
CoC requirement. If they do not meet the CoC standard 3.3 requirements, as previously outlined 
in the purpose and rationale, they will no longer be deemed a cancer center. This illustrates the 
importance of survivorship care planning and the impact that is has on its stakeholders.  
This inquiry has lead to the clinically relevant PICO question, “In breast cancer 
survivors, how does a survivorship care plan compared to standard follow-up care affect 
survivors’ confidence in cancer self-care knowledge and care satisfaction?”  
Search Strategy 
An exhaustive search was conducted in order to answer this clinical inquiry. CINAHL 
(Appendix A), PubMed (Appendix B), and PsychINFO (Appendix C) were the three databases 
searched to retrieve valid, reliable, and applicable literature. Key search terms included: 
survivorship, care plan, care plans, or care planning, survivorship care plan, survivorship care 
plans, survivorship care planning, cancer survivorship, cancer, neoplasm, breast cancer, breast 
neoplasm, survivor, breast cancer survivor, confidence, self-efficacy, satisfaction, health 
promotion, follow-up recommendations, and follow-up adherence.  
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CINAHL (Appendix A) was first searched using the Boolean connectors AND/OR. 
Survivorship care plans and breast cancer or breast neoplasm yielded 38 articles. Using the term 
cancer or neoplasm, which produced a yield of 44 articles, further expanded this search. The only 
limiting factor included in this initial search was a published date between 2013-2107. 
Additional searches were conducted for each outcome metric. The Boolean connector AND 
connected survivorship care plan or survivorship care plans to: cancer or neoplasm, breast cancer 
or breast neoplasm, survivor confidence, confidence, satisfaction, health promotion, follow-up 
recommendations, and follow-up adherence. Sixty-seven articles in total generated after these 
searches. No limitations, inclusion, or exclusion criteria were set on these searches due to the 
limited yield of articles.  
 A similar search was conducted in the PubMed database (Appendix B). Terms 
survivorship, care plan or care plans, and cancer or neoplasm were connected with the AND 
connector. The initial yield included 281 articles. This search was further limited to 81 articles 
by using the terms breast cancer or breast neoplasm instead of the general terms cancer or 
neoplasm. Including the term care planning within this same search yielded three additional 
articles. Outcome metrics were included within additional searches. Survivorship care plan or 
survivorship care plans were connected using the Boolean connector AND to cancer or 
neoplasm, breast cancer or breast neoplasm, confidence, satisfaction, health promotion, and 
follow-up recommendations. In total these searches yielded 137 articles. The limiter applied was 
that each term must be within the title or abstract of the article. 
 PsychINFO (Appendix C) was the final database searched. Initially 160 articles generated 
from the connected search terms of cancer survivorship and care plan or care planning. This 
search was condensed to 136 through the limiter of publication date from 2013-2017. Survivor or 
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breast cancer survivor was connected to previously searched terms through the AND connector. 
The limiter of publication date was removed. This search yielded 138 articles. In order to review 
articles that were specific to the clinical question’s population, breast cancer or breast neoplasm 
was connected to survivorship and care plan or care planning. Fifty-five articles were found to 
relate to this search.  
 Saturation was met based upon the reoccurrence of articles within each database. 
Between the three databases the final field was 259, however, many of these articles were 
duplicates, were not peer reviewed studies, and included childhood cancers, therefore they were 
discarded. Forty articles were further reviewed and appraised. Article exclusion continued if they 
were published prior to 2013, examined provider preference only, had limited generalizability 
due to modest sample diversity, had poorly structured descriptive and statistical data, and were 
irrelevant to the clinical inquiry. Eleven articles remained and were selected for further 
evaluation due to their quality and relevance to the clinical question (Appendix D).  
Critical Appraisal & Synthesis  
Eleven studies were retained after rapid critical appraisal. With regard to the level of 
evidence, four were level one (systematic reviews [SRs]), three were level two (randomized 
control trials [RCTs]), and four were level four: one cohort study, one feasibility study, and two 
cross-sectional studies (MeInyk & Fineout-Overholt, 2015). The majority of studies were 
conducted in the United States, and all were quantitative studies expect one. The quality of the 
chosen studies was deemed to be high after thorough review (Appendix D).  
Sample size among level II-IV evidence ranged from 79 to 1,615 participants. The 
studies’ demographic information revealed moderate homogeneity, which could result in bias of 
outcome data. No biases were specifically mentioned (Appendix D). All eleven studies involved 
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adult cancer survivors with a variable mean age ranging from 37 to 75 years. All studies had 
more female participants than male, and most participants were survivors of breast or colorectal 
cancer (Jefford et al, 2016). Four studies evaluated breast cancer survivors; one study evaluated 
colorectal cancer survivors, while the remaining studies evaluated a variation of breast, 
colorectal, gynecological, and other non-specified malignancies.  
 The primary intervention, implementation of SCPs, was evaluated across all studies. 
Three studies addressed SCPs along with treatment summaries (TS) as an intervention, while two 
studies addressed SCP plus a survivorship visit (SCPSV) as an intervention. Content and 
distribution of SCPs revealed heterogeneity. The outcomes of interest addressed across the 
studies included: quality of life, satisfaction, survivorship care knowledge, coordination of care, 
follow-up to recommended guideline adherence, survivor distress, and survivor self-efficacy 
(Appendix E). Self-efficacy and follow-up guideline adherence were the two variables that had 
the least representation, therefore, research efforts tat evaluate these variables are necessary  
(Appendix E). This information demonstrates value in the development of a project with the 
focus of improving survivorship care.  
There is heterogeneity of measurement tools. Most measurement tools were reported as 
being valid and reliable, however, it was difficult to assess because each study used distinct 
questionnaires and surveys. Potential for bias is apparent for the studies using surveys due to 
their subjective nature (MeInyk & Fineout-Overholt, 2015). Reliability and validity was 
demonstrated in all studies. (Appendix D).  
The overarching themes that were found, in relation to outcomes, were improved patient 
satisfaction and coordination of care. These outcomes were significantly demonstrated in five of 
the eleven appraised studies after SCP implementation. Another outcome that presented 
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significant improvement across multiple studies was survivorship care knowledge. The SCP 
intervention that included survivorship visits demonstrated the most significant outcome 
evidence (Appendix E).   
To date the results of SCP implementation have been inconclusive. It is unknown as to 
what factors are playing into these results. Despite this, there have been significant benefits in 
patient satisfaction, coordination of care, and survivorship care knowledge. Application of these 
significant findings in research and evidence-based practice projects could result in more 
significant data and SCP process improvement (Appendix D).  
Purpose Statement 
This evidence has lead to the initiation of an evidence-based quality improvement 
project. Breast cancer survivors that meet CoC survivor eligibility are the population of choice. 
This is based on evidence that breast cancer is the most prevalent cancer for those to survive and 
the most prominent cancer type. Through the involvement of stakeholders such as: the cancer 
center’s nursing research manager, nursing informatics, multidisciplinary oncology providers, 
the cancer registry, and the chosen SCP vendor team, data was collected to evaluate the cancer 
center’s compliance to CoC standard 3.3 requirements and breast cancer survivors’ confidence in 
cancer self-care knowledge and care satisfaction pre/post the initiation of a specific survivorship 
visit where a SCP was delivered. The prospect of this pilot project is to meet CoC standard 3.3 
requirements and bring understanding to SCPs function in cancer survivorship care. 
Models 
The Mayo Clinic Nursing Evidence-Based Practice Model (MCNEBP) was selected to 
guide the implementation of the proposed evidence-based SCP pilot intervention. This seven-
step model was developed to guide practice change within Mayo for the purpose of assuring the 
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use of best practice for attaining the best patient outcomes (Mayo Clinic, 2017). The MCNEBP 
Model is specific to the Mayo Clinic and its patients, therefore, appropriateness of setting and 
population is apparent. The seven steps include: formulate a question, search for evidence, 
appraise the evidence, compare and contrast, decision options, evaluate, and disseminate. An 
aspect unique to this model that is specific to SCP implementation is step five. There are four 
decision options to choose from after comparing and contrasting evidence. If strong evidence is 
in support of a change then the implementation of a practice change can occur, and if the 
evidence is inconclusive the options are to place the project on hold, implement a quality 
improvement project, or a research study (Mayo Clinic, 2017). Although the evidence for SCP 
implementation is inconclusive patient satisfaction, coordination of care, and cancer care 
knowledge elicited improvement; therefore, through the guidance of this model a project will be 
initiated using the significant data found for facility quality improvement. This model will 
further guide this project through evaluation and dissemination. SCPs effectiveness will be 
evaluated through a pre and post questionnaire, and findings will be disseminated through 
internal and external presentations. 
The Chronic Care Model (CCM) further guides SCP implementation within the cancer 
center. This model came about to correct the deficits that were present in the management of 
chronic disease. The goal of this model is to attain proactive disease management instead of 
reactive, which has resulted in improved care and patient outcomes (Improving Chronic Illness 
Care, 2017). In correlation to this project, the goal of SCPs is to improve the deficits that are 
present in cancer survivorship care; therefore, the CCM was adopted to guide the content and 
structure of SCP implementation. The six fundamental elements that make up this model 
includes: the community, the health system, self-management support, delivery system design, 
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decision support, and clinical information systems. Each element includes a change concept that 
is necessary for element improvement. These change concepts include: to meet patients’ needs 
through community resources, to create a health system that fosters safe and high quality care, 
patient empowerment and preparation in regards to their health and the care they should receive, 
effective and efficient care that supports self-management, promotion of care that is based off of 
evidence and patient preference, and readily assessable patient/population data to attain care that 
is efficient and effective. Evidence demonstrates that the products of combining these elements 
and their change concepts include healthier patients, satisfied providers, fiscal savings, improved 
patient-provider communication, improved patient participation in care, and enhanced utilization 
of provided resources in respect to chronic disease care (Wagner, 1998). The creation of a 
survivorship visit and the information that is included within the SCPs has been based upon these 
elements and change concepts. All elements and concepts have been incorporated into a 
personalized SCP. Breast cancer survivors will receive their SCP at a survivorship visit in the 
hope to improve their survivorship care from that of their current standard follow-up care. Using 
this model generates SCP component structure and connection, which in turn assists project 
development, implementation, and potential practice change.  
Methods 
An evidence-based quality improvement project was initiated within an accredited cancer 
center in Arizona. A SCP intervention was delivered at a survivorship visit to eligible adult 
breast cancer patients. The CoC’s survivor eligibility criteria included breast cancer patients 18 
and older that were treated with curative intent for an initial cancer occurrence. The CoC also 
required SCPs to be delivered within one year of patients’ cancer treatment completion. CoC 
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eligible breast cancer survivors included in the pilot were identified retrospectively by the 
organization’s cancer registry.  
Prior to the implementation of the intervention the organization’s breast cancer providers 
received SCP and project workflow education. This multi-disciplinary education was conducted 
for the purpose of optimizing the SCP delivery process. Starting in August 2017 identified 
survivors were scheduled for a survivorship visit. Prior to the visit SCPs were created by a 
registered nurse care coordinator and then reviewed and finalized by an oncology provider. The 
SCPs were reviewed and delivered by the oncology provider at a specified survivorship visit and 
included four essential elements: description of specific cancer diagnosis, treatments received, 
instruction for follow-up care, and health promotion recommendations. Survivors perceived 
confidence in cancer self-care knowledge and care satisfaction was measured using the 
Confidence in Survivorship Information Questionnaire (CSI). This 13-item questionnaire 
measures survivors’ confidence in their knowledge of cancer diagnosis, treatment, 
prevention/treatment of late disease/treatment effects, disease prevention, accessibility to 
resources, and family cancer risk (Palmer, Jacobs, Mao, & Stricker, 2012). With permission from 
the creators of the CSI three items were added to the questionnaire to address survivor care 
satisfaction. Although there is no known validity to date, the reliability of this instrument is set 
upon two subscales. The first three items of the questionnaire address survivor knowledge of 
their cancer diagnosis and treatment and have a Cronbach’s alpha of 0.77 (Palmer, Jacobs, Mao, 
& Stricker, 2012). The last 10 items have a Cronbach’s alpha of 0.95. This information 
demonstrates relevance to evaluation questions and reliability of the instrument. The CSI utilizes 
a three-point Likert scale with numerical values ranging from 1 (not at all confident) to 3 (very 
confident), whereas a 5-point Likert scale with numeric values ranging from 5 (very satisfied) 
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to 1 (very dissatisfied) was utilized for the evaluation of patient care satisfaction. Questionnaires 
were completed prior to receiving their SCP at the survivorship visit. Post CSI questionnaires 
were completed by phone in February 2018. The doctorate of nursing practice student contacted 
initial survey project participants by phone and followed an Institute of Review Board (IRB) 
script. A paired T-test analysis, alpha 0.5, was used to evaluate SCP effectiveness. Throughout 
the pilot the organization’s adherence to CoC standard 3.3 requirements was evaluated by 
tracking the number of survivors identified as needing a SCP, number of SCPs delivered, 
percentage of the two, and percentage of the correct SCP sent to health information 
management systems (HIMS) per provider.  
Project IRB approval was obtained by ensuring the protection of survivors’ privacy and 
rights through data being stored in encrypted servers/files, which were locked in cabinets. Also, a 
username and password protected encrypted access. All protected health information complied 
with HIPPA rules. The only individuals granted access to material were those who participated 
in the project or provided direct care to the patient. Data was stored for the duration of pilot 
project, and expires 24 months from project initiation. 
Results  
Data demonstrated an increase in the delivery of SCPs from zero to 57, and a practice 
change adherence (SCP delivery) of 84 percent from August 2017 to January 2018. Survivors 
and providers verbalize value in SCPs. Twenty-two breast cancer survivors completed a pre CSI 
questionnaire and 20 of those completed a post CSI questionnaire. No statistical significance was 
found in the comparison of SCPs effect on survivors’ confidence in cancer self-care knowledge 
and care satisfaction to that of standard follow-up care; however, when comparing the pre and 
post questionnaire averages an improvement was noted across the board. Survivors’ confidence 
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in their knowledge of: preventing and treating long-term physical effects, community resources 
available to them, family cancer risk, family risk information, and overall care satisfaction were 
the areas of most clinical significant improvement post survivorship visit and SCP delivery. For 
graphical representation of CSI questionnaire statistical and average findings reference appendix 
G and H.  
Discussion  
Throughout this project a team-based approach was utilized. The organization’s 
colorectal practice implemented SCPs through a workflow that was slightly different from 
breast’s. This team-based approach was shown useful through CSI questionnaire findings. An 
overall improvement in breast and colorectal cancer survivors' confidence in cancer self-care 
knowledge and care satisfaction was demonstrated, which is consistent with current literature 
and supports the continuation of SCP delivery. The colorectal practice identified significance in 
results unlike the breast practice. This was most likely due to their provider workflow 
consistency. Unfortunately provider inconsistency occurred in the breast practice due to an 
unexpected absence. This resulted in acquiring other providers who did not receive as extensive 
of education on SCP workflow and delivery as the original provider. This contributed to missed 
survivorship consults and delivery inconsistency due to a variation in eligible survivor 
identification. Organization compliance requires continued improvement to reach future SCP 
delivery recommendations; however, this project enhances current research findings in the fact 
that SCP effect is increased through consistency in provider education and the use of a focused 
survivorship visit. Project limitations included a small sample size and a six-month observation 
time. Another six months would have not only added to the sample size, but also allowed for the 
evaluation of SCP delivery effect on patient outcomes such as: National Comprehensive Cancer 
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Network follow-guideline adherence and health promotion behaviors (vaccine adherence and 
smoking cessation). The cost of the vended SCP product may be viewed as a burden by some, 
however, the reduction in cost of care through improvements in survivors’ self-efficacy and 
disease prevention and health promotion practices may decrease the use of unnecessary 
healthcare resources. With this outcome vended SCP products may be viewed as a cost saving. 
Future research should include larger sample sizes and further investigation to identify the best 
SCP tool and delivery process.  
Conclusion 
SCP delivery through a strategically designed survivorship visit shows to be an 
operational framework that improves the transition from cancer patient to survivor. This project 
aids as a guide for organization SCP implementation and CoC standard 3.3 requirement 
compliance. The implementation of SCPs at a survivorship visit not only serves as a device to 
instill greater confidence in survivors’ cancer self-care knowledge, but also improves survivors’ 
overall care satisfaction. In the end, effectively empowering cancer survivors in their 
survivorship transition has the potential to improve their chances for long-term survival and 
optimize their quality of life.  
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Evaluation Table  
 
Citation Conceptual 
Framework 
Design/Method Sample/Setting Major Variables & 
Definitions 
Measurement Data 
Analysis 
Findings Decision for Use in 
Practice/Application to 
Practice 
Boekhout, A. H. 
(2015). A 
survivorship care 
plan for breast 
cancer survivors: 
Extended results of 
a randomized 
clinical trial 
 
Country: Canada 
 
Disclosure/Conflict 
of Interest: None to 
disclose  
 
Funding: Canadian 
Breast Cancer 
Research Alliance  
Inferred:  
Change theory 
 
Pender’s HPM 
 
Conducts the 
progress of 
health 
promotion 
interventions.  
Design:  
Randomized 
Control Trial  
 
Purpose: 
Determine 
whether SCP 
utilization in BC 
patients 
improved 
patient-reported 
outcomes/health 
care utilization 
when 
transitioning 
care to PCP.  
 
N= 408 
 
N I=164 
N C=173 
 
MA intervention: 61.9 
(SD: 10.2) 
MA control:  
61 (SD: 10.2) 
 
TOT, I: TM: 47, BCS: 
117. R:133, CT: 68, 
HT: 113 
 
TOT C: TM: 42, 
BCS:131, R: 143, CT: 
71, HT: 130 
 
MFD, I: <24 mo.:70 
>/=24mo: 94 
 
MFD, C: <24mo: 69 
>/=24mo: 104 
 
Inclusion Criteria: early 
stage breast CA, no 
recurrence or 
secondary cancer. 
Completed primary 
>/=3 months to 
IV1: SCP  receipt 
IV2: No SCP receipt 
 
DV1: CSD, 
DV2: HRQL 
DV3: PS 
DV4: CCC 
DV5: GA 
Questionnaires 
at baseline, 3, 
6, 18, and 34 
months. 
Telephone 
interviews at 9, 
15, and 21 
months.   
 
Impact of 
Event Scale 
(IES), Profile 
of Mood States 
questionnaire 
(POMS), 
Physical and 
Mental 
Component 
SP-36 
summary 
scales (PSC, 
MSC), the 
Medical 
Outcomes 
Study-Patient 
Satisfaction 
Questionnaire 
(MOS-PSQ), 
and the CCCQ 
 
 All analyses 
were 
performed 
with SAS 
version 9.1 or 
R version 
2.7.1  
DV1-5 No 
difference between 
control/intervention 
group.  
 
 
LOE: II  
 
Strengths: generalizable 
to practice settings; 
sample size; looked at 
short-term and long-term 
benefit/sustainability of 
SCPs 
 
Limitations: adherence 
score based upon patient 
self-report; misclassified 
tests as routine when 
they are diagnostic; IES 
sensitivity  
 
Applicability/Feasibility: 
Further research must be 
conducted in 
determining the essential 
elements of SCPs that 
provide benefit for 
survivors prior to a 
widespread 
implementation.  
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unmet needs measure, CC: colon cancer, CCC: continuity and coordination of care, CCCQ: coordination of care questionnaire, CDa: complete data CHC: 
childhood cancer, CS: cancer survivors, CSD: cancer specific distress, CT: chemo therapy, DS: disease stage, DV: dependent variable, EOL: end of life, EORT: 
European organization for research and treatment, ES: entire sample, F: female, FCI: follow-up care intervention, FU: follow-up, G: group, GA: guideline 
adherence, GC: gynecological cancer, GSI: global severity index, HC: health care, HPM: health promotion model, HRQL: health related quality of life, HT: 
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enrollment, Established 
PCP for FU care 
 
Exclusion Criteria: 
persistent 
complications of 
primary treatment, 
previously enrollment 
in continuous oncology 
FU, primary cancer 
other BC, shared PCP 
with another study 
participant 
 
AR:71 
 
Brennan, M.E. 
(2014). 
Survivorship care 
plans in cancer: a 
systematic review 
of care plan 
outcomes 
 
Country: Australia  
 
Disclosures/Conflict 
of Interest: unstated  
 
Funding: The 
Friends of The 
Mater Foundation  
Inferred: 
Henderson 
Need Theory 
 
Qualify of life 
theory- based 
from Maslow’s 
theory of needs. 
Design:  
Systematic 
Review 
 
Purpose:  
Review 
evidence of SCP 
implementation 
in practice.  
N= 2,286 participants. 
 
Articles n=10 
n=5 RCT’s 
n=5 non RCTs 
 
TOC:  
BC, CC, GC, CHC 
 
Mean age range:  
37-62 
 
Inclusion criteria: 
original studies 
evaluating written care 
plans for CS, and 
reporting HRQL, and 
SOC  
 
Exclusion criteria: 
articles evaluating SCP 
in metastatic disease, 
and studies that 
evaluated a single 
IV1: paper 
based/online SCP 
IV2: 
oncologist/nurse/PCP 
delivered SCPs 
IV3: Other SCP 
templates 
 
DV1: Survivor 
distress 
DV2: CCC 
DV3: oncological 
outcomes 
DV4: ability to 
identify FU provider 
DV5: change in 
unmeet needs 
 
Cancer 
Survivor 
Unmet Needs 
Scale 
 
Multiple likert 
scales 
 
EORT quality 
of life 
questionnaire  
 
Brief symptom 
inventory 18 
 
“QualSyst” 
tool for SR 
 
Descriptive 
statistics, 
multivariate  
regression, t-
test 
 
No significant 
findings related to 
distress, care 
coordination, 
satisfaction, or 
cancer outcomes. 
 
SCPs improved 
survivor follow-up 
clinician 
identification 
(p=0.005).  
 
Higher Satisfaction 
with SCPs, 
understanding of 
SCP, and CCC  (did 
not meet statistical 
significance) 
 
 
 
 
LOE: I 
 
Strengths: heterogeneity 
in SCP content. 
Represent data from 
2,288 cancer survivors.   
 
Limitation: small 
amount of 
heterogeneous literature; 
few RCTs.  
 
Lack of homogeneity 
between cancer type/ 
stage of disease. 
 
Inconsistency in 
evaluation tools. 
 Ceiling effect in SCP 
satisfaction.  
 
Applicability: evidence 
supports increased 
patient satisfaction and 
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AR: attrition rate, BC: breast cancer, BCS: breast conserving surgery, BRFSS: behavioral risk factor surveillance system, C: Control, CaSUN: cancer survivors’ 
unmet needs measure, CC: colon cancer, CCC: continuity and coordination of care, CCCQ: coordination of care questionnaire, CDa: complete data CHC: 
childhood cancer, CS: cancer survivors, CSD: cancer specific distress, CT: chemo therapy, DS: disease stage, DV: dependent variable, EOL: end of life, EORT: 
European organization for research and treatment, ES: entire sample, F: female, FCI: follow-up care intervention, FU: follow-up, G: group, GA: guideline 
adherence, GC: gynecological cancer, GSI: global severity index, HC: health care, HPM: health promotion model, HRQL: health related quality of life, HT: 
hormone therapy, I: intervention, IOM: institute of medicine, IV: independent variable, N/n: number, M: male, MA: mean age, MFD: months from diagnosis, 
MS: marital status, PC: palliative care, PCP: primary provider, POSTCARE: patient-owned survivorship transition care for activated, empowered survivors, PR: 
peer reviewed, PRO: patient reported outcomes, PS: patient satisfaction, QLS: qualitative study, QTS: quantitative study, RCT: randomized control trial RT: 
radiation therapy, SCP: survivorship care plan, TM: total mastectomy, TOC: type of cancer, TOT: type of treatment U: unknown,  y/o: years-old 
 
variable of care 
 
AR: N/A 
self-reported 
understanding of 
survivorship care.  
 
Feasibility: SCPs took 1-
4 hours to develop.  
 
Bulloch, K. J. 
(2015). Systematic 
approach to 
providing breast 
cancer survivors 
with survivorship 
care plans: a 
feasibility study 
 
Country: USA 
 
Disclosure/Conflict 
of Interest: Several 
authors provide 
disclosures  
 
 
Funding: American 
Society Grant 
 
 
 
 
Inferred:  
Explanatory 
Theory  
 
Pender’s HPM 
Design:  
Pre/post 
feasibility study 
 
Purpose:  
1. Assess 
feasibility of 
SCPs.  
2. Determine if 
knowledge of 
diagnosis, 
treatment, and 
risk of long term 
adverse event 
improved post 
receipt of SCP.  
N= 67 total sample 
CDa: n=51 
 
MA;, ES 55.9  
MA, CDa: 56.8 
 
DS, ES:  
Stage 1: n=32 
Stage 2: n=25 
Stage 3: n=11 
 
DS, CDa:  
Stage 1: n=24 
Stage 2: n-19 
Stage 3: n=8 
 
TOT, ES:  
RT: n=43 
C: n=36 
HT: n=52 
 
TOT, CD: 
RT: n=36 
CT: n=29 
HT: n=39 
 
AR:16 
 
Setting:  
Smilow Cancer 
Hospital Breast Center 
at Yale –New Haven, 
 
IV1: care prior to 
SCP 
IV2: care post SCP  
 
DV1: feasibility 
DV2: diagnosis 
knowledge 
DV3: treatment 
knowledge 
DV4: Knowledge of 
risk for long-term 
adverse effects.  
 
 
Three self-
administered 
surveys at 
baseline visit 
and two 
surveys at F/U 
visit. 
 
Impact of 
events scale, 
profile of 
mood states 
questionnaire, 
physical and 
mental 
component SF-
36 
Multivariable 
logistic 
regression 
analysis  
DV2: improved 
understanding of 
cancer stage at F/U 
visit post SCP 
receipt (not 
significant) 
 
DV4: improved 
understanding of 
risk of leukemia at 
F/U visit post SCP 
receipt (p=0.0348) 
 
84% patient 
satisfaction with 
SCP 
LOE: IV 
 
Strengths: First study of 
its kind 
 
Limitations: Small 
sample size; information 
was collected from 
single health care system 
(not a generalized 
population); adverse 
events were not 
personalized to 
treatment  
 
Applicability/feasibility: 
With the improvement 
in patient survivorship 
knowledge it is feasible 
to deliver SCPs to breast 
cancer survivors at their 
post-op visit.  
SURVIVORSHIP CARE PLANNING  31    
 
AR: attrition rate, BC: breast cancer, BCS: breast conserving surgery, BRFSS: behavioral risk factor surveillance system, C: Control, CaSUN: cancer survivors’ 
unmet needs measure, CC: colon cancer, CCC: continuity and coordination of care, CCCQ: coordination of care questionnaire, CDa: complete data CHC: 
childhood cancer, CS: cancer survivors, CSD: cancer specific distress, CT: chemo therapy, DS: disease stage, DV: dependent variable, EOL: end of life, EORT: 
European organization for research and treatment, ES: entire sample, F: female, FCI: follow-up care intervention, FU: follow-up, G: group, GA: guideline 
adherence, GC: gynecological cancer, GSI: global severity index, HC: health care, HPM: health promotion model, HRQL: health related quality of life, HT: 
hormone therapy, I: intervention, IOM: institute of medicine, IV: independent variable, N/n: number, M: male, MA: mean age, MFD: months from diagnosis, 
MS: marital status, PC: palliative care, PCP: primary provider, POSTCARE: patient-owned survivorship transition care for activated, empowered survivors, PR: 
peer reviewed, PRO: patient reported outcomes, PS: patient satisfaction, QLS: qualitative study, QTS: quantitative study, RCT: randomized control trial RT: 
radiation therapy, SCP: survivorship care plan, TM: total mastectomy, TOC: type of cancer, TOT: type of treatment U: unknown,  y/o: years-old 
 
Inclusion criteria: 
confirmed diagnosis 
BC staged 1-3. BC 
surgery at stated 
setting, >18 y/o, 
English literacy 
 
Exclusion criteria: 
stage 0 or metastatic 
disease.   
 
Jefford, M. (2016). 
A randomized 
controlled trial of a 
nurse led supportive 
care package 
(SurvivorCare) for 
survivors of 
colorectal cancer 
 
Country: Australia  
 
Disclosures/Conflict 
of Interest/Funding: 
Denied financial 
relationships  
Inferred:  
Social 
Cognitive 
Theory  
 
Pender’s HPM 
Design:  
Randomized 
Control Trial  
 
Purpose:  
Evaluate 
effectiveness of 
SCP/care 
package on 
psychological 
distress, HRQL, 
unmet info. 
needs, and 
psychosocial 
outcomes in CR 
CS. 
 
N= 217 
N I= 106 
N C= 110 
 
Median age: 64 
(M: 52% F:48%) 
 
TOC: CC(56%), RC 
(35%), OLS (10%) 
 
SOD: S1 (7%) , S2 
(22%),  S3 (71%) 
 
AR: 1 
 
Inclusion criteria: 
confirm diagnosis of 
CC or CR, stage I-III 
disease, rx w/ curative 
intent.  >18 y/o, 
English speaking  
 
Exclusion criteria: 
cognitive/psychological 
impairment, 
determined too unwell 
to participate, hx of 
other malignancy with 
exception of non-
IV1: SurvivorCare 
IV2: Usual Care 
 
DV1: Psychological 
distress 
DV2: HRQL 
DV3: Change in 
Unmet needs.  
BSI-18 and 
GSI 
 
European 
organization 
for research 
and treatment 
(EORTC QLQ 
C-30) 
 
Ideals of 
Survivorship 
care survey 
(self 
developed) 
 
 CaSUN 
SPSS 
statistics. 
Descriptive 
statistics 
T test (Mann-
whitney U)  
and Chi-
square tests as 
appropriate. 
 
Hochberg’s 
modify 
Bonferroni 
test for 
primary 
outcome 
analysis.   
No difference in 
Distress and HQOL 
between IV1 and 
IV2 
 
IV1 more satisfied 
with multiple 
aspects of post 
treatment care 
(p=<0.05 on 10 of 
15 questions about 
perception of care) 
LOE: II 
 
Strengths: validation of 
strong sensitivity and 
appropriateness of 
assessment tools. 
N>100, Diagnosis 
homogeneity.  
 
Limitations: 
Heterogeneity of 
baseline cancer 
distress/time since 
diagnosis.  
 
Applicability: 
Demonstration of 
intervention usefulness 
in elements of 
survivorship care.  
 
Highest usefulness in 
patients with higher 
CaSUN scores.  
 
Feasibility: Research 
needs to carefully 
identify study endpoints.  
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melantanomous skin 
cancer, and enrollment 
in a conflicting 
supportive care trial 
 
Keesing, S. (2015). 
Cancer survivors’ 
experiences of using 
survivorship care 
plans: a systematic 
review of 
qualitative studies 
 
Country: USA 
 
Disclosure/Conflict 
of Interest/Funding: 
None 
Inferred: 
Self-care theory 
 
1. Addresses 
knowledge and 
experience  
 
2. Influences 
cancer patients’ 
self- reliance 
and 
responsibility 
for  care.  
 
Pender’s HPM 
Design:  
Systematic 
Review 
 
Purpose:  
Review and 
document 
current 
qualitative 
literature that 
examines CS’s 
experience 
using SCPs. 
N= 11 qualitative 
studies.  
Interview: n= 4, 
Focused groups: n= 6 
Action research: n= 1 
 
Range of number of 
participants: 7-40. 
 
TOC:  
BC: n= 7, 
CC: n= 2 
other: n= 3 
 
Inclusion criteria:  
>/= 18 y/o, publication 
2000-2014, published 
in English 
Exclusion criteria:  
Abstract only, studies 
that examined 
palliative phase of 
disease, or experience 
of cancer treatment. 
 
AR: N/A  
IV: Use of SCP 
 
DV : CS perspective 
on SCPs and 
experiences of SCP 
use in care.  
KMET (close 
method 14 
item)  
Critical 
appraisal: 
Standard 
quality 
assessment 
criteria for 
evaluating 
primary 
research 
papers from a 
variety of 
fields by 
Kamet, lee 
and cook.  
 
SCP: Significant 
reduction of 
duplicate materials, 
improved CCC, and 
increased 
communication 
between survivor 
and health care 
provider. 
LOE: I 
 
Strengths: first published 
qualitative SR. 11 
databases included. 
Utilized validated 
methods/tools for 
conducting SR.   
 
Limitations: Difference 
in amount of qualitative 
data.  
 
Applicability/Feasibility:  
SCPs found to be 
practical tool in 
survivorship care. Future 
research to examine 
practical issues related 
to delivery across a 
variety of care contexts.  
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Kenzik, K. M. 
(2016). Treatment 
summaries and 
follow-up care 
instructions for 
cancer survivors: 
Improving survivor 
self-efficacy, and 
healthcare 
utilization 
 
Country:  USA 
 
Disclosure/Conflict 
of Interest: None 
stated  
 
Funding: 
Department of 
Health and Human 
Services  
 
 
 
 
 
 
 
 
 
 
 
 
 
Inferred:  
Social 
Cognitive 
Theory 
 
Design: 
Cross-Sectional  
 
Purpose:  
Examine how 
treatment 
summaries 
(SCP) both 
written and 
verbal are 
associated with 
self-efficacy and 
healthcare 
utilization. 
 
N= 441 
  
MA: 74.7 
F(60%) M (40%) 
 
Education:  
LSE: 49% 
 
TOC:  
prostate and breast 
cancer 
 
Mean time from 
diagnosis: 4.6 years 
 
Setting:  
hospital based; 12 
different sites across 
Alabama, Georgia, 
Mississippi, Florida, 
Tennessee 
 
AR = 0 
 
Inclusion Criteria: CS 
who had completed 
treatment,  follow 
completion of initial 
survey and were >/= 2 
years  
 
Exclusion criteria: 
incomplete survey, < 2 
years post treatment 
IV1: Delivery of 
written summary of 
cancer treatment w/ 
SCP by health 
professional  
IV2: written 
summary of SCP w/o 
explanation.   
IV3: verbal delivery 
of  FU care plan w/o 
written summary. 
  
DV 1: ER visits 
DV 2: 
hospitalizations 
 
Stanford 
chronic illness 
self-efficacy 
scale  
 
Study pertinent 
developed 
questions:  
SCP type/ 
delivery. 
ER visits/ 
hospitalization 
in last year,  
Primary 
analysis: 3 
multiple 
linear 
regression 
models 
 
Exploratory 
analysis: 
Mediation 
analysis to 
estimate 
association 
between 
variables 
Post Hoc 
analysis  
 IV1: increased self-
efficacy scores 
(B=0.72, SD=0.27, 
p=0.009) and 
decreased 
emergency room 
visits/hospitalization 
 
DV1-DV2 
decreased 
significantly with 
IV1 
 
LOE: IV 
 
Strengths: large sample 
size, evaluation of 
several HC sites. 
Evaluation of older 
cancer survivors. 
Use of validated 
measurement tool.  
 
Limitations: reliance on 
patient self-report of 
SCP type/delivery.  
Patient-provider 
relationship/recollection 
of information= 
influence of self-efficacy 
scores. Lack of insight 
to content or 
standardization of SCPs. 
 
Applicability/feasibility:  
Suggestion: SCPs 
influence survivor’s 
behavior/health 
outcome.  
 
Future research: 
Examine how SCPs help 
survivors, identify how 
to effectively implement 
verbal SCP explanation  
 
 
Klemanski, D. L. 
(2016). 
Survivorship care 
plan preferences of 
cancer survivors 
and health care 
Inferred: 
Explanatory 
Theory  
 
Design:  
Systematic 
Review 
 
Purpose: 
Describe and 
N= 29 total  
 
Quantitative= 19 
RCT= 3 
Pre/post test= 1 
Survey with descriptive 
IV: SCP use  
IV2: usual care 
 
Patient variables:  
DV 1: Survivorship 
experiences 
Focus groups, 
individual 
interviews 
 
Mixed 
methods 
Critical 
appraisal: 
Quality 
assessment 
tool for QTS 
Joanna Briggs 
SCP: Improved 
CCC between PCP 
and oncologist.  
 
Improved survivor 
understanding of 
LOE: I 
 
Strengths: large amount 
of heterogeneous data 
 
Limitations: mostly 
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providers: a 
systematic review 
and quality 
appraisal of the 
evidence.  
 
Country: 
US Publication 
(included reviews 
published in Canada 
and Australia) 
 
Disclosure/Conflict 
of Interest/Funding: 
None 
 
examine the use 
of treatment 
summaries and 
SCP in current 
practice, as well 
as critically 
appraise 
relevant 
literature 
regarding 
preferences and 
usefulness of 
SCP in practice.  
analysis= 15 
Qualitative= 10 
 
Study characteristics:  
Survivor perspectives 
(N=20) 
Cancer survivor 
perspective only 
(N=14) 
 
Survivor and provider 
perspective (N=6) 
 
TOC: BC (n=10) CC 
(n=3) GC (n=1), other 
malignancies (n=6) 
 
 
Settings:  
cancer centers, 
oncology clinics, 
tertiary care centers, 
community cancer 
centers 
 
Inclusion:  
QLS or QTS related to 
preference of items to 
be incorporated in 
SCPs, reported by CS, 
care givers, or health 
care providers,  Studies 
published Jan 2005-
Dec 2013, Original 
work/ PRJ, English,  
 
Exclusion:  
study addressed 
PC/hospice/EOL care, 
pertained survival and 
DV 2: Quality of 
care 
DV 3: Satisfaction 
(with collaborative 
communication 
between care 
providers) 
DV4: Perceived gaps 
in CS care 
DV 5: Delivery of 
SCP 
 
Provider variables:  
DV 1 : Perceived 
barriers to SCP 
implementation 
DV 2: Role 
clarification in SCP 
DV 3: Confidence in 
management of CS 
care.  
 
appraisal tool  
 
Transparent 
reporting of 
evaluation with 
non-
randomized 
design  
Institute’s 
qualitative 
assessment 
and review 
instrument. 
survivorship care. 
 
 
exploratory studies. 
Narrow gender/TOC 
focus. Heterogeneity in 
SCPs format/HC 
settings.  
 
Applicability/feasibility: 
Improved follow-up care 
(provider/patient 
perspective).  
 
Future research: 
identify/prioritize patient 
preferences in 
survivorship care, and 
SCP delivery across 
settings  
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mortality statistics, 
targeted sample was 
pediatric or adolescent 
oncology, secondary 
works.  
 
AR: N/A 
 
Kvale, E. A. (2016). 
Patient-centered 
support in the 
survivorship care 
transition: 
Outcomes from the 
patient-owned 
survivorship care 
plan intervention  
 
Country: USA 
 
Disclosure/Conflict 
of Interest: Three 
authors received 
support from 
National Institute  
of Health 
 
Funding: Grant 
support from 
American Cancer 
Society  
Explicitly 
states: 
POSTCARE 
conceptual 
model; derived 
from chronic 
care model/IOM 
survivorship 
policies  
 
Pender’s HPM 
Design:  
Randomized 
Control Trial  
 
Purpose:  
Determine the 
impact that the 
POSTCARE 
intervention had 
on patient 
outcomes/care 
coordination.  
N= 79 
I: n-40 
C: n=39 
 
MA, I: 57.23 
MA, C: 59.51 
 
TOC: breast 
 
TOT, I: 
LNB: n=32 
LND: n=17 
CT: n=23 
RT: n=27 
S: n=40 
 
TOT C; 
LNB: n=30 
LND: n=9 
CT: n=18 
RT: n=26 
S: n=39 
 
Inclusion criteria:  >/= 
19 y/o, non-metastatic 
disease, completion of 
treatment within one 
year  
Exclusion criteria: 
outside of one year of 
active treatment 
 
IV 1: POSTCARE 
intervention 
 
IV 2: usual care 
 
DV1: HRQL 
DV2: Depression 
DV3: Self efficacy 
and self-management 
 
Health literacy: 
Rapid estimate 
of adult 
literacy in 
medicine-short 
form.  
 
Comorbidity: 
Charleston 
comorbidity 
index 
 
HQOL: 36-
item short-
form health 
survey 
 
Depression:  
PHQ-9  
 
Limitations, 
social 
role/activities: 
4-item 
social/role 
activities 
limitation.  
 
Self-
management: 
13-item patient 
activation 
SPSS: 
Version 22 
and SAS 
version 9.4. 
Descriptive 
analysis: 
demographics 
and treatment 
characteristic. 
 
Chi-square 
test for 
comparison 
between 
groups 
regarding 
frequency. 
 
Student t test 
for within 
group 
comparison.  
 
Generalized 
linear model 
used to 
examine 
effect of 
intervention 
coordination 
and patient 
reported 
IV 1: lower social 
role limitations 
(p=0.014), and 
higher self efficacy 
(0.07) .  
 
IV 1: higher self 
reported health 
(p=0.017). 
 
IV 1: Three HQOL 
domains had 
meaningful 
improvement at 3 
mo. FU: physical 
role (p=0.009), 
bodily pain 
(p=0.03), emotional 
role (p=0.04).  
 
LOE: II 
 
Strengths: examines 
several variables, use of 
valid measurements 
tools.  
 
Limitations: population 
(breast patients only); 
not generalizable. Small 
sample size. Limited 
power. Long-term effect 
not captured.  
 
Applicability: Support 
and emphasis of data 
about importance of 
providing a SCP and 
health care providers 
role in discussing 
content.  
 
Feasibility: Future 
research to identify how 
HC provider can deliver 
SCP (effectively, 
sensible, and with 
impact)  
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measure-short 
form.  
 
Self efficacy: 
Self efficacy 
for managing 
chronic disease 
6-item scale 
outcomes. 
Mayer, D. K. 
(2015). Summing it 
up: an integrative 
review of studies of 
cancer survivor care 
plans 
 
Country: USA 
 
Disclosure/Conflict 
of Interest: None 
 
Funding: The 
University of North 
Carolina  
Mentioned: 
Dobediam 
Model 
 
Design: 
Integrative 
Review 
 
Purpose:  
Summarize 
current 
scientific 
knowledge, and 
empirical data 
regarding SCP 
in adult CS, and 
identification of 
knowledge gaps 
in survivorship 
care 
N= 42 studies 
 
Populations:  
CS 
HCP 
 
Categories of Focus: 
1.Content of SCP 
2.Dissemination/ 
Implementation 
3.Survivor/provider 
outcomes 
 
AR: 0 
 
Inclusion Criteria:  
results of empirical 
study, CS diagnosed at 
>/= 18 y/o, relate to 
cancer and report 
findings that associated 
with SCPs 
Exclusion Criteria:  
IV: SCP 
 
DV 1: SCP content  
DV 2: SCP  
dissemination and 
implementation 
DV3: survivor and 
provider outcomes  
  
 
 
Interviews, 
focus groups, 
and multiple 
unspecified 
survey tools  
 PRISMA Discrepancy 
between HC 
providers/survivors 
in desired SCP 
content 
 
Improved PCP-
reported 
CCC/confidence in 
survivorship 
knowledge (p<0.05) 
 
Lack of info. on 
delivery preference 
Few studies found 
patients preferred 
delivery right before 
or directly after 
treatment.  
 
Only 12.5% of 
patients received 
SCP (10 cancer 
LOE: I 
 
Strength: evaluation of a 
vast amount of evidence. 
Both provider and 
survivor perspectives 
evaluated.   
 
Limitations: 4 high level 
studies availability. 
Limited generalizability 
(lack of diversity).  
Weak testing of data 
measurement tools   
 
Applicability: Low SCP 
receptivity/ 
implementation 
 
Feasibility: Future 
research to address SCP 
methodology, content , 
and outcomes.   
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abstracts or 
presentations,  adult 
survivors of childhood 
cancer, and non-
empirical data 
 
 
programs)  
 
 
Oancea, S. C. 
(2016). 
Psychological 
distress among adult 
cancer survivors: 
Importance of 
survivorship care 
plan.  
 
Country: USA 
 
Disclosure/Conflict 
of Interest/Funding: 
None 
 
 
 
 
Inferred: 
Health Belief 
Model  
 
Pender’s HPM 
Design:  
Cross-sectional  
 
Purpose:  
To examine 
association 
between 
recipient of SCP 
and 
psychological 
distress in adult 
cancer survivors 
post treatment.  
N= 3,191 
 
G1: CS 1-5 y from 
diagnosis 
N:1046 
Median age: 58.85 
F (n=610) 
M (n=436) 
 
Received FCI: n:789 
Received TS: n:366 
 
G2: CS >5 y from 
diagnosis 
N:2145 
Median age: 64.52 
F (n=1463) 
M (n=682) 
EL: 
LTS: N=173 
S: n=709 
SC: n=573 
CD or more: n=690 
Received SCI: n=1424 
IV 1: TS only 
IV: FCI only 
IV: TS + FCI  
IV 4: non TS or FCI 
 
DV 1: Psychological 
distress 
  
Behavioral risk 
factor 
surveillance 
system 
questionnaire.  
 
Cancer 
survivorship 
and anxiety 
and depression 
modules 
Descriptive 
statistics.  
 
Critical 
analysis: SAS 
b 9.4, using 
survey 
procedures. 
 
Multivariable 
weighted 
logistic 
regression 
(investigate 
association 
between 
variables) 
Short-term cancer 
survivors: Distress 
3x higher if only 
FCI receipt, as 
compared to FCI + 
TS (AOR= 3.14, 
95% CI [1.29-
7.65]).  
 
Long-term cancer 
survivors: distress 
was 2x higher only 
FCI receipt (AOR= 
2.18, 95% CI [1.14-
4.19]). 
LOE: IV 
 
Strengths: sample size, 
first study to look at 
long-term distress.  
 
Limitations: 
underrepresentation of 
TS, but no FCI group. 
Pain severity/comorbid 
conditions not controlled 
or assessed. Questions 
subject to recall; 
potential bias  
 
Applicability: SCPs has 
potential to enhance 
short/long-term 
psychological well-
being.  
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Received TS; n=611 
 
Setting: Telephone 
survey based from 
BRFSS registry 
 
Inclusion criteria: 
Cancer diagnosis at 
>/=18 y/o, not pregnant 
at time of study, >1 
year post diagnosis.  
 
Exclusion: incomplete 
survey completion 
 
Feasibility: Future 
research to investigation 
SCP implementation 
barriers.  
 
Palmer, S. C. 
(2015). Outcomes 
and satisfaction 
after delivery of a 
breast cancer 
survivorship care 
plan: Results of a 
multi-center trial 
 
Country: USA 
 
Disclosure/Conflict 
of Interest: Authors 
provided disclosure, 
but no conflict of 
interest  
 
Funding: Livestrong 
Foundation  
Inferred:  
Theory 
Reasoned 
Action. 
 
Pender’s HPM 
 
Design:  
Perspective 
Cohort 
 
Purpose:  
Explore the 
outcomes 
associated with 
delivery of 
comprehensive 
SCP to BC 
survivors.   
N= 139 
 
MA: 53.93 
Mean MFD: 3.43 
Stage at diagnosis:  
Stage 0: n=10 
Stage 1: n=52 
Stage 2 n=51 
Stage 3 n=21 
 
TOT:  
CT; 93 
HT: 96 
 
Mean SF-12 mental 
health score: 54.38 
(sd:11.19) 
Mean SF-12 physical 
health score: 47.97 
(sd:8.85) 
 
Setting:  
Seven NCI designated 
comprehensive cancer 
IV1: Care prior to 
SCP 
IV2: SCP delivery 
 
DV1: SCP utilization 
DV2: satisfaction 
DV3: knowledge 
DV4: CCC 
 
 
Quality of 
Life: Medical 
study short 
form (SF)- 12 
 
SCP materials: 
16-item 
investigatory 
developed 
survey see 
table 2.  
 
Satisfaction: 
global 
satisfaction on 
5-likert scale.  
 
Perceived 
coordination,  
knowledge, 
behavior was 
assessed 
(measurement 
tool not stated)  
Weak 
description of  
statistical 
methods: 
software  
 
Descriptive 
statistics: 
Cronchbach’s 
alpha, and t-
test  
 
SCP utilization: 
IV2: SCP use: 64% 
for decision to 
exercise, 62% for 
dietary changes, and 
62% for directing 
FU care.  
 
SCP satisfactions: 
90% satisfied 
 
Knowledge:  
IV2 improved 
perceived 
survivorship 
knowledge/ CCC 
(p=<0.001)  
 
 
LOE: II 
 
Strengths: sample 
characteristics,  cancer 
settings. Pre and post 
assessment, high 
retention, Standardized 
visits/materials  
 
Limitations: Quasi-
experimental design, 
narrow demographic 
population, tools (self 
made). Self-report vs. 
chart abstraction 
 
Applicability: suggests 
SCPs/delivery 
standardization across an 
array of settings. Useful 
in new BC survivors.  
 
Feasibility:  
Success at all sites 
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centers and their 
community practices.  
 
Inclusion criteria:  >/= 
18 y/o, diagnosis and 
treatment of primary 
BC or DCI, completion 
of cancer therapy, and 
scheduled survivorship 
visit  at SCOEN 
 
Exclusion criteria:  
unable to complete 
inform consent d/t 
barriers,  and previous 
recipients of SCPs 
 
 
 
suggests with 
institutional 
commitment, financial, 
and logistical support 
SCPs can be effectively 
delivered   
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Appendix E 
Synthesis Table  
 
 
 
 
 
 
 
 
 
  Studies 
Bo
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ho
ut
 
Br
en
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n 
Bu
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Je
ffo
rd
 
K
ee
sin
g 
K
en
zi
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K
le
m
an
sk
i 
K
va
le
 
M
ay
er
 
O
an
ce
a 
Pa
lm
er
 
 
Year 2015 2014 2015 2016 2015 2016 2016 2016 2015 2016 2015 
LOE II I VI II I VI I II I VI II 
Design RCT SR FS RCT SR CS SR RCT SR CS PCS 
Length 24m N/A 2m 6m N/A 1d N/A 3m N/A 1d 3m 
SCP X X X  X X X  X X X 
SCPSV    X    X    
TS      X X   X  
QOL NS   NS   NS     
S NS           
SCK            
COC NS       NS    
FUGRA NS           
SD NS NS  NS   NS     
HPB            
SE            
 
CS: cross-sectional study, COC: coordination of care, FS: feasibility study, FUGRA: follow-up 
guideline recommendation adherence, HPB: health promotion behaviors, LOE: level of evidence, NS: 
not significant, PC: perspective cohort study, QOL: quality of life, RCT: randomized control trial, S: 
satisfaction, SCK: survivorship care knowledge, SCP: survivorship care plan, SCPSV: survivorship 
care plan survivorship visit, SD: survivor distress, SE: self-efficacy, SR: systematic review, TS: 
treatment summary 
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Appendix F 
Evidence-Based Practice Model  
 
© 2017 Mayo Foundation for Medical Education and Research. 
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Appendix G 
CSI Questionnaire Analysis 
 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) 
95% Confidence 
Interval of the 
Difference 
Upper 
Pair 1 Type - Type2 .333 .370 19 .716 
Pair 2 Stage - Stage2 .215 .000 19 1.000 
Pair 4 Prevent - Prevent2 .159 -.809 19 .428 
Pair 5 Physical Effects  - Physical 
Effects2 
.263 .000 19 1.000 
Pair 6 Prevent Physical Effects - 
Prevent Physical Effects2 
.007 -2.042 19 .055 
Pair 7 Treat Physical Effects - Treat 
Physical Effects2 
.088 -1.453 19 .163 
Pair 8 Emotional Effects - Emotional 
Effects2 
.215 .000 19 1.000 
Pair 9 Prevent Emotional Effects - 
Prevent Emotional Effects2 
.189 -.438 19 .666 
Pair 10 Treat Emotional Effects - Treat 
Emotional Effects2 
.200 -.438 18 .667 
Pair 11 Community Resources - 
Community Resources2 
.260 -.767 19 .453 
Pair 12 Family  Risk - Family  Risk2 .133 -1.287 18 .215 
Pair 13 Family  information - Family  
information2 
.202 -1.073 18 .297 
Pair 14 Survivorship care - Survivorship 
care2 
.379 -.644 17 .528 
Pair 15 Wellness - Wellness2 .349 -1.031 17 .317 
Pair 16 Health Promotion - Health 
Promotion2 
.121 -1.699 17 .108 
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Appendix H 
Pre/Post CSI Questionnaire Averages 
 
 
 
 
 
2.8 2.8 2.9
2.3
2.8 2.9 3.0
2.4
Type Stage Treatments Prevent
Confidence in Diagnosis, 
Treatment, and Prevention
Series1 Series2
2.4
2.1 2.3
2.5 2.5 2.52.4 2.5 2.6
2.6 2.6 2.6
Physical
Effects
Prevent
Physical
Effects
Treat
Physical
Effects
Emotional
Effects
Prevent
Emotional
Effects
Treat
Emotional
Effects
Confidence in Long-term Effects
Series1 Series2
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2.4
2.3 2.3
2.6
2.6 2.6
Community Resources Family  Risk Family  information
Confidence in Resources and Risk
Series1 Series2
4.7
4.3
4.2
4.9
4.6 4.7
Survivorship care Wellness Health Promotion
Satisfaction
Series1 Series2
